Clinical Case Study: Craving Reduction Provided by NicoSwab™

Figure 3: NicoSwab™ provided craving relief starting at minute 7, and craving reduction occurred for 113 minutes on average. By comparison, craving relief with Nicorette Gum® started at minute 20, and the relief lasted approximately 40 minutes.

Figure 3: NicoSwab™ provided craving relief starting at minute 7, and craving reduction occurred for 113 minutes on average. By comparison, craving relief with Nicorette Gum® started at minute 20, and the relief lasted approximately 40 minutes.

During ART’s pharmacokinetic trial of NicoSwab™, smokers filled out a standardized questionnaire. The participants not only experienced craving relief significantly more quickly and longer with NicoSwab™ compared to Nicorette® gum, but the patients strongly preferred not having to chew or suck throughout their day, avoiding the unpleasant side effects of these activities. They liked that NicoSwab™ could be used less frequently than gums or lozenges (video of exit interviews available.) When the same smokers chewed gum in our study, they received minimal relief from cravings and wanted to smoke again. When the same smokers used an oral spray mist, the uncomfortable, burning feeling throughout their mouth was unacceptable. The oral spray did provide some immediate relief from cravings, but not long-term sustained relief, when compared to NicoSwab™. In summary, the data from these trials confirmed that NicoSwab™ reduces cravings almost immediately and over several hours. The immediate and prolonged impact of NicoSwab™, combined with its ease of use and reduction in side effects, will not only improve the chances of a smoker quitting but will drive accelerating OTC sales.